A: Agilent Technologies Projected Sales Volume

Corporate emblem and logo of Agilent Technologies, Inc. (A)

The complex transportation of Agilent Technologies (A) precision equipment requires special protective measures, which impacts costs. The company's expected realization level on GURU.Markets confirms this trend, and 9.74 becomes the new value for this indicator. Growth is supported by the automation of laboratory software for bioanalysis and the planned modernization of nucleic acid synthesis capacities at production sites.

Company Revenue Forecast: agilent.com (A) for 07/04/2022 - 11/15/2026

Financial and market metric breakdowns for Agilent Technologies (A)

- stock value and consensus price forecast:
Summary company analysis:Agilent Corp
Product sample of Agilent Corp

Due to the low demand elasticity for high-precision equipment and software for pharma R&D, Agilent Technologies (A) maintains significant pricing power. Mathematically scrubbing quotes of market manipulations regarding the company's sales expectations allows for the identification of the real fundamental trend, eliminating random price spikes and warning the investor of the risks of purchasing the asset at a local peak.

Competitors of Agilent Technologies (A)

Company Future Sales Volume DGX (questdiagnostics.com)|Company Future Sales Illumina Inc|Exact Sciences - Company Future Sales Volume|Revvity, Inc. (RVTY) - Company Expected Sales Volume|BIO: Company Future Sales Volume|NNNN: Company Projected Revenue|Sotera Health (SHC) - Company Projected Revenue|Company Revenue Forecast QDEL|OPK (OPKO Corp) - Projected Sales Volume|Company Revenue Forecast CDNA (CareDx, Inc)|Projected Sales Volume MRVI|Fulgent Genetics - Company Revenue Forecast|Projected Sales Volume LAB (Fluidigm)|Cytek Biosciences - Company Projected Revenue|OSUR: Company Future Sales Volume|XGN (exagen.com) - Company Revenue Forecast|MDXH: Projected Sales Volume|Lucid Diagnostics Inc. (LUCD) - Projected Sales Volume|PRE (Prenetics Global) - Projected Sales Volume|Company Expected Sales Volume imdxinc.com IMDX|Company Projected Revenue Trinity Biotech plc (TRIB)|Projected Sales Volume ProPhase (PRPH)|Projected Sales Volume AIMD (ainos.com)|Company Future Sales Co-Diagnostics, Inc. (CODX)|heartsciences.com - Projected Sales Volume|Biomerica, Inc (BMRA) - Company Future Sales Volume|Cardio Diagnostics (CDIO) - Company Projected Revenue|ONCO - Company Future Sales|VRAX (Virax Biolabs Corp) - Projected Sales Volume|Bluejay Diagnostics, Inc. (BJDX) - Company Future Sales|Projected Sales Volume AWH|Accelerate Diagnostics Inc. - Company Revenue Forecast|Centogene - Company Future Sales Volume|Enzo Biochem, Inc. (ENZ) - Company Expected Sales Volume|Company Projected Revenue Volume Fresh2 Group Limited FRES|Company Future Sales gtglabs.com GENE|23andMe Holding Co (ME) - Company Projected Revenue|Company Revenue Forecast PMD